GlassScriptPhysician profile
Thomas F Smith
NPI 1346207917
$939.39
in general payments reported to CMS, 2019-2025
18 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $56.16 · 2022: $60.00 · 2023: $196 · 2024: $70.41 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $225.94 | 2019-2024 | |
| Glaxosmithkline, LLC. | $136.73 | 2019-2025 | Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $92.10 | 2019-2023 | Fasenra |
| Kaleo, INC. | $73.44 | 2019-2023 | Auvi-Q |
| Stryker Corporation | $60.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $59.26 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.63 | 2022-2025 | Takhzyro |
| Regeneron Healthcare Solutions, INC. | $37.87 | 2019 | |
| Hospira, INC. | $34.58 | 2024-2025 | |
| Ars Pharmaceuticals Operations, INC. | $27.48 | 2025 | Neffy |
| Leo Pharma INC. | $26.90 | 2024 | Adbry |
| Grifols USA, LLC | $21.80 | 2023 | Xembify |
| Greer Laboratories, INC. | $18.60 | 2019 | |
| Aimmune Therapeutics, INC. | $17.94 | 2022 | |
| Shire North American Group INC | $16.77 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $16.25 | 2019 | |
| Octapharma USA, INC. | $13.67 | 2019 | |
| Pfizer INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.